In the previous study on the molecular mechanism of the action of Elian granules on precancerous lesions of gastric cancer through network pharmacology, we found that the active components of Elian granules can regulate the activation factors of M2-type macrophages, such as IL-4 and IL-10 [13]. This evidence concerns the gene IL10 and gastric cancer.